College Statements Update
All College Statements are revised every two years. This revision
and update process is undertaken by the Women's
Health Committee 
(WHC) of the College.
All WHC recommendations for revision, updating, re-endorsement
or retirement of College Statements are then submitted to the College
Council for approval.
The RANZCOG Council meets three times a year (March, July and November)
and information about revised and updated Statements is posted here
after each meeting.
New College Statements
Approved at Council - March 2009
C-Obs 30
 (43 KB)
|
Suitability Criteria for Models of Care and Indications for Referral within & between Models of Care 
March 2009
First Endorsed - July 1994
Review Due - March 2012
Several sentence, wording and reference amendments were made. The sentence ‘There is an association between DMPA use and weight gain (mean of 3kg after 2 years of use (6).)’ was added at the end of the fourth paragraph. The last paragraph was slightly rephrased and extended. Adjustments of several reference numbers occurred, due to additional references being added to the ‘References’ section of the statement. |
Recently Revised College Statements
Approved at Council - March 2009
C-Obs 22
(589 KB) |
Use of prostaglandins for cervical ripening prior to the induction of labour
March 2009
First Endorsed - July 2006
Next Review Due - March 2012
Minor amendments were made to this statement. Under the subheading ‘Recommendations’, an extra sub-point ‘v. Management of Uterine Hyperstimulation should such occur’ was added to point b. |
C-Gyn 4
(595 KB) |
Depot
Medroxyprogesterone Acetate (Depo Provera)
March 2009
First Endorsed - July 1994
Review Due - March 2012
Several sentence, wording and reference amendments were made. The sentence ‘There is an association between DMPA use and weight gain (mean of 3kg after 2 years of use [6]).’ was added at the end of the fourth paragraph. The last paragraph was slightly rephrased and extended. Adjustments of several reference numbers occurred, due to additional references being added to the ‘References’ section of the statement. |
C-Gyn 12
(48 KB) |
Tamoxifen
and the endometrium
November 2006
First Endorsed - May 1996
Review Due – March 2012
This statement was re-endorsed with one minor change. The word endometrioid was included to dot point two. |
C-Gyn 17
(46 KB) |
Termination
of pregnancy
March 2009
First Endorsed - March 2005
Review Due - March 2012
Few but noteworthy were made to this statement. The last sentence under the sub-heading ‘Access’ was rephrased. The paragraph under the sub-heading ‘Workforce’ was extended with the following sentence: ‘A systematic approach is required to ensure recruitment and training of sufficient health professionals to provide safe clinical care, including procedures when indicated, for women dealing with unplanned or unwanted pregnancy.’ The section under legislation was re-written and now reads: ‘Legislation regarding termination of pregnancy varies across jurisdictions. It is essential that health practitioners are aware of the legislation that applies in the jurisdiction in which they practice. Uniformity and clarity of legislation would benefit both health practitioners and the women for whom they care.’ |
C-Gen 9
(33 KB) |
Assessment of Competency
November 2008
First Endorsed - November 2006
Review Due – Nov 2011
Few amendments were made, though the most significant change was the extension of the last paragraph. The last paragraph now explains the process of written request for assessment and review; how RANZCOG members are selected as reviewer and assessor; and how members are to approach the reviews and assessments in the role of reviewer and assessor. |
C-Gen 10
(33 KB) |
Use of Non-medical Ultrasound
November 2006
First Endorsed - November 2006
Review Due – June 2011
This statement was re-endorsed with minor wording amendments. These amendments occurred in the last paragraph which now reads as follows:
Appropriate regulation by appropriate authorities regarding the sale, distribution and use of diagnostic ultrasound equipment should be formulated with a view to ensuring that this technology continues to assist clinicians in the management of pregnancy, thereby optimizing outcome for mothers and babies. |
C-Trg 1
(39 KB) |
Guidelines
for training in advanced endoscopic surgery and endometrial ablations
March 2009
First Endorsed - March 1994
Review Due - March 2012
Previously titled: 'Guidelines for training in advanced endoscopic surgery'
Two minor changes occurred to this statement: the inclusion of point six; and the addition of a link to college statement C-Trg 2: Guidelines for performing advanced operative laparoscopy. |
WPI 14
(191 KB) |
RANZCOG / ANZCA / RACGP / ACCRM Position Statement on the provision
of obstetric anaesthesia services
March 2009
First Endorsed - March 2004
Review Due - March 2012
This statement was re-endorsed with updated web links. |
© RANZCOG
|
